Archives

Fortrea Holdings Inc. (NASDAQ: FTRE) disclosed that director David Ross Smith received 6,598 additional common shares on July 20, 2026, following a tax withholding adjustment related to the settlement of restricted stock units that vested in June. The issuance represents a true-up of shares withheld for tax purposes when the RSUs originally vested on June 10, 2026. Smith's total beneficial ownership of common stock following the transaction stands at 36,715 shares, held directly.

• July 27, 2026 07:32 AM PDT
• Vinay Lochav

McCormick & Company Inc. (NYSE: MKC-V) disclosed that Michael Aaron Conway, a director of the spice and seasoning manufacturer, acquired 1,100 shares of common stock on July 23, 2026, at a price of $50.2067 per share. The transaction, filed on July 27, 2026, reflects Conway's direct ownership position in the company. Following the acquisition, Conway's total beneficial ownership of McCormick common stock stands at 18,852 shares held directly, according to the filing.

• July 27, 2026 07:32 AM PDT
• Aakashdeep

Christopher M. Green, Vice President of Accounting at Smart Sand, Inc. (NASDAQ: SND), sold 1,738 shares of common stock on July 23, 2026, at $4.81 per share in a transaction related to restricted stock vesting. The transaction occurred as shares were withheld for tax purposes upon the vesting of restricted stock awards. Following the disposal, Green maintained beneficial ownership of 48,167 shares of the company.

• July 27, 2026 07:32 AM PDT
• Anjali Anand

Dwight Eric Smith, a director of Peoples Bancorp Inc. (NASDAQ: PEBO), acquired 1,000 shares of common stock on July 23, 2026, at a price of $39.8099 per share in an open market purchase. The transaction, disclosed in a filing dated July 27, 2026, brings Smith's total beneficial ownership to approximately 10,256.1792 shares held directly. The acquisition signals continued confidence in the Ohio-based financial institution from a member of its board of directors.

• July 27, 2026 07:32 AM PDT
• Anjali Anand

Snehal Patel, Chief Executive Officer and Chief Financial Officer of Greenwich LifeSciences, Inc. (NASDAQ: GLSI), has disclosed significant purchases of company common stock totaling 3,600 shares across two trading days in late July 2026. The purchases, filed with the Securities and Exchange Commission on July 27, 2026, bring Patel's direct beneficial ownership to approximately 5.6 million shares. The disclosure signals insider confidence in the biopharmaceutical company at a time when investors closely monitor executive trading activity for signals about business prospects.

• July 27, 2026 07:32 AM PDT
• Aakashdeep

Rozenberg Haine Yael, Vice President of Finance at Valens Semiconductor Ltd., sold 2,750 ordinary shares on July 23, 2026, at a weighted average price of $1.7257 per share, according to a regulatory disclosure filed on July 27, 2026. The transaction was executed under a Rule 10b5-1 trading plan that the executive adopted on March 17, 2026. Following the sale, Yael beneficially owns 137,942 ordinary shares in the semiconductor company.

• July 27, 2026 07:31 AM PDT
• Vinay Lochav

Swarmer Inc (NASDAQ: SWMR) announced a realignment of its senior management team on July 24, 2026, effective immediately. Alexander Fink, who has served as the company's U.S. Chief Executive Officer and President, will assume expanded responsibilities and become the company's principal executive officer, reporting directly to the Board of Directors. The company disclosed that Fink's compensation will remain unchanged in connection with this leadership transition.

• July 27, 2026 07:31 AM PDT
• Manish Choudhary

Twenty One Capital, Inc. disclosed that Chief Executive Officer Raphael Zagury presented the company's strategic priorities at the Mining Disrupt 2026 conference on July 22, 2026. During a fireside chat, Zagury discussed the company's approach to building a Bitcoin-native operating company through disciplined capital allocation, risk management, and investments in operating businesses and capital markets capabilities. The disclosure provides insight into management's vision for long-term shareholder value creation and the metrics the company plans to use to measure success.

• July 27, 2026 07:31 AM PDT
• Shwetambri Chauhan

Balchem Corporation announced on July 24, 2026, that it has amended its credit agreement with JPMorgan Chase Bank and JPMorgan SE, substantially expanding its financial flexibility. The company increased its revolving credit commitment by $100 million to $650 million total and extended the maturity date to July 24, 2031, while also securing more favorable borrowing terms. The amendment reflects lender confidence in Balchem's financial position and provides the company with enhanced liquidity to support operations and strategic initiatives.

• July 27, 2026 07:31 AM PDT
• Vinay Lochav

Forte Biosciences, Inc. has entered into a definitive merger agreement with argenx BV, a Belgian biopharmaceutical company, under which argenx will acquire Forte for $77.00 per share in an all-cash transaction announced on July 26, 2026. The transaction is structured as a two-step process consisting of a tender offer followed by a merger, with Forte's board of directors unanimously recommending that stockholders accept the offer. The acquisition represents a significant strategic move in the biopharmaceutical sector and is expected to proceed subject to customary closing conditions and regulatory approvals.

• July 27, 2026 07:30 AM PDT
• Manish Choudhary